Article Information
History
- September 19, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alexis Audibert1,2,
- Xavier Mas-Orea2,
- Léa Rey2,
- Marcy Belloy1,
- Emilie Bassot1,
- Gilles Marodon3,
- Frederick Masson1,
- Nicolas Cenac2,
- Gilles Dietrich2,
- Chrystelle Bonnart2,*,@ and
- Nicolas Blanchard1,*,@
- 1Toulouse Institute for Infectious and Inflammatory Diseases, Infinity, Inserm, CNRS, University Toulouse III, Toulouse, France
- 2IRSD, Inserm, INRAE, ENVT, University Toulouse III - Paul Sabatier (UPS), Toulouse, France
- 3Centre d’Immunologie et des Maladies Infectieuses (CIMI-PARIS), Inserm, CNRS, Sorbonne University, Paris, France
- ↵@co-corresponding authors, Nicolas Blanchard (nicolas.blanchard{at}inserm.fr), Chrystelle Bonnart (chrystelle.bonnart{at}inserm.fr)
Posted September 19, 2024.
Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling
